Merakris Therapeutics Secures FDA Agreement for Type C Meeting to ...
Sep 30, 2025 · RESEARCH TRIANGLE PARK, N.C., September 30, 2025 (GLOBE NEWSWIRE) — Merakris Therapeutics, a regenerative medicine company developing biologic drug therapies for hard …
Dermacyte AC Matrix - Merakris Therapeutics
Dermacyte® AC Matrix Amniotic Membrane Allograft includes both amnion and chorion membrane and is prepared by a proprietary process that includes cleaning, disinfection, rinsing, cutting, …
Merakris Therapeutics Spotlights Investigational New Drug, MTX-001 ...
Jul 24, 2025 · MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs) RESEARCH TRIANGLE PARK, N.C., July 24, 2025 (GLOBE …
Wound Healing Technology Company Merakris Adds ... - Merakris …
Aug 15, 2023 · RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) — Merakris Therapeutics has added two new executives to its leadership team as it prepares to expand its …
Merakris Therapeutics Enrolls 30th Subject in Expanded Access …
Sep 4, 2025 · Enrollment milestone and ongoing study to be highlighted at SAWC Fall 2025; Merakris expanding clinical trial site partnerships RESEARCH TRIANGLE PARK, N.C, Sept. 04, 2025 …
Merakris Therapeutics Introduces Dermacyte® AC Matrix: A …
Oct 1, 2024 · Merakris to showcase new Lyophilized Amnion Chorion Allograft at the Fall Symposium for Advanced Wound Care (SAWC) in Las Vegas at booth 440 on October 2-5, 2024. RESEARCH …
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., September 30, 2025 (GLOBE NEWSWIRE) — Merakris Therapeutics, a regenerative medicine company developing biologic drug therapies for hard-to-heal …
Merakris Therapeutics Announces Open Enrollment for Phase II Clinical ...
Dec 10, 2024 · Merakris aims to deliver a first-in-class drug and pioneer a new era within the wound care industry by commercializing regenerative medicine for hard-to-heal wounds RESEARCH …
Merakris Therapeutics Announces Completion of Type C Meeting with …
Dec 4, 2025 · RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) — Merakris Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative biologic …
T. Christopher Broderick - Merakris Therapeutics
Jan 15, 2024 · Chris Broderick brings over 15 years of biotechnology industry experience to his role as Founder, President and Chief Executive Officer of Merakris Therapeutics. Since founding Merakris in …